Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

BioCorRx (BICX) Accumulated Depreciation & Amortization (2016 - 2025)

BioCorRx's Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at $186866.0 for Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 14.74% year-over-year to $186866.0; the TTM value through Sep 2025 reached $186866.0, up 14.74%, while the annual FY2024 figure was $175574.0, 22.26% up from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2025 was $186866.0 at BioCorRx, up from $183468.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $186866.0 in Q3 2025 and bottomed at $71222.0 in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $130769.0 (2023), against an average of $131029.4.
  • The largest annual shift saw Accumulated Depreciation & Amortization soared 434.64% in 2021 before it grew 14.74% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $91708.0 in 2021, then grew by 28.65% to $117979.0 in 2022, then grew by 21.72% to $143608.0 in 2023, then increased by 22.26% to $175574.0 in 2024, then rose by 6.43% to $186866.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Accumulated Depreciation & Amortization are $186866.0 (Q3 2025), $183468.0 (Q2 2025), and $179338.0 (Q1 2025).